Drug Topics May 2021

More than a year into the COVID-19 pandemic, the mental health burden resulting from the public health crisis is becoming more and more apparent.

Innovation is everywhere, but cumbersome pharmacy technology remains an issue.

Pharmacist inclusion in stroke interventions improves patient outcomes.

Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.

Ease patients’ concerns by being well versed in the safety profiles of each vaccine.

Pharmacists can play an important role as part of an interdisciplinary team in treating patients with rheumatoid arthritis.

Technology and mobile health apps can be valuable tools in diabetes management.

More opportunities are emerging for pharmacists to fine-tune their patients’ regimens and serve as important access points for individuals experiencing mental health crises.